A MULTI-CENTER, RAMDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL OF METFORMIN

二甲双胍的多中心、随机、安慰剂对照、双盲试验

• 批准号: 7380734
• 负责人: Carine M Lenders
• 金额: $ 1.7万
• 依托单位: BOSTON CHILDREN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-04-01 至 2007-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7380734
• 关键词: MULTI; CENTER; RAMDOMIZED; PLACEBO; CONTROLLED

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is to find out if the drug metformin (Gloucophage XR, Bristol -Myers Squibb Co. Inc) will help obese, non-diabetic adolescents lose weight . We will find this out by comparing one group of subjects that will take metformin to another group who will not take the drug.

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子弹和调查员（PI）可能已经从其他NIH来源获得了主要资金，因此可以在其他清晰的条目中代表。列出的机构适用于该中心，这不一定是调查员的机构。这项研究是为了找出药物二甲双胍（Gloucophage XR，Bristol -Myers Squibb Co. Inc）是否会帮助肥胖，非糖尿病青少年减肥。我们将通过比较一组将二甲双胍与不会服用该药物的组的受试者进行比较来发现这一点。